• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Omni Bio Pharmaceutical, Inc. (OMBP)

    -OTC BB
    0.36 Up 0.05(16.13%) Jan 29, 10:19AM EST
    Add to Portfolio
    Prev Close:0.31
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:0.81
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.15 - 0.45
    Volume:0
    Avg Vol (3m):32,908
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMBP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company in the United States. It holds a license to use patent for the treatment of diabetes using plasma-derived alpha-1 antitrypsin (p-AAT), a protein that is purified from human blood. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback